Financial statements Amber Pharm
Balance sheet of Amber Pharm
Company age:
Age:
14 y. 8 m. 29 d.
Share capital:
Share capital:
300 000 PLN
Balance sheet data of AMBER PHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 8 561 103,67 | 9 448 494,69 | 12 549 960,06 | 15 513 359,54 |
| A. Fixed assets | 2 165 151,90 | 1 983 599,54 | 3 535 937,76 | 3 367 661,35 |
| B. Current assets | 6 395 951,77 | 7 464 895,15 | 9 014 022,30 | 12 145 698,19 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 8 561 103,67 | 9 448 494,69 | 12 549 960,06 | 15 513 359,54 |
| A. Equity | 1 547 389,88 | 2 043 792,33 | 3 349 850,78 | 5 342 292,42 |
| B. Liabilities and provisions for liabilities | 7 013 713,79 | 7 404 702,36 | 9 200 109,28 | 10 171 067,12 |
| I. Long-term liabilities | 286 936,94 | 188 884,00 | 1 093 982,00 | 802 992,00 |
| II. Short-term liabilities | 6 511 979,83 | 7 148 726,36 | 7 919 224,00 | 9 106 446,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.